ACR Appropriateness Criteria ® on External Beam Radiation Therapy Treatment Planning for Clinically Localized Prostate Cancer
Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110-1032, USA.International journal of radiation oncology, biology, physics (Impact Factor: 4.26). 05/2009; 74(3):667-72. DOI: 10.1016/j.ijrobp.2008.12.073
- Nature Reviews Clinical Oncology 05/2010; 7(5):249-50. DOI:10.1038/nrclinonc.2010.59 · 14.18 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Intensity-modulated radiotherapy (IMRT) offers dosimetric benefit for irregularly shaped treatment volumes compared to three-dimensional conformal approaches. Some groups advocate IMRT as the standard of care for prostate radiotherapy. For clinicians, assessment of an IMRT plan can introduce new opportunities and challenges. Although a standard IMRT plan may be deemed acceptable by meeting pre-set dose constraints, further optimisation may yield a superior treatment plan by further reducing dose to critical structures or improving target volume homogeneity. The aim of this article is to present aspects of IMRT planning relevant to clinicians to aid in plan critiquing.Journal of Medical Imaging and Radiation Oncology 12/2010; 54(6):569-75. DOI:10.1111/j.1754-9485.2010.02217.x · 1.11 Impact Factor
Chapter: Prostate[Show abstract] [Hide abstract]
ABSTRACT: Given the high global incidence of prostate cancer, it represents one of the most common diseases treated in radiation oncology and urological clinics. It also represents a disease where technological innovations are often introduced and evaluated before they are advanced to other disease sites. In this chapter we describe an array of acceptable methods for the curative treatment of prostate cancer, from conventional radiation therapy techniques, intensity modulated radiation therapy, stereotactic body radiation therapy, brachytherapy, and proton therapy. The choice of modalities used in any given clinical situation is often determined by its technical availability, as no “level one” evidence exists to demonstrate clinical outcome superiority of one technique to another. We also discuss the definitive management of patients with brachytherapy and the post-operative management of patients who have adverse pathologic factors or have failed radical prostatectomy. Discussions on appropriate immobilization and localization techniques are provided. Finally, prescription methods and normal organ dose constraints for the various techniques of radiation therapy are given.Technical Basis of Radiation Therapy, 01/2011: pages 949-1025;
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.